EXO.AS Exor N.V. (EURONEXT) earnings 23 Mar 2026: NAV and €64.85 market signal

EXO.AS stock faces an investor test as Exor N.V. reports results on 23 Mar 2026. Market closed and the share sits at €64.85, near the 52-week low of €63.35. Investors will watch NAV updates, Ferrari stake moves and cash flow from disposals. This earnings spotlight focuses on valuation, cash generation and the implications for short-term price action.

EXO.AS stock: earnings calendar and market context

Exor N.V. reports after the close on 23 Mar 2026. The company trades on EURONEXT in Europe and closed today at €64.85 with volume 257,458. Recent disposals and dividend flows shape the NAV story ahead of the release. Reuters coverage of recent asset sales and strategic moves provides current context

Earnings preview: what to watch in the report

Key items: NAV per share movement, dividends received and proceeds from previous asset sales. Watch commentary on Ferrari holdings and uses of the €3.00 billion proceeds from past share sales. Management guidance and cash flow clarity will drive near-term investor reaction.

Financials and valuation: cash rich but earnings negative

Exor shows EPS -2.99 and PE -21.19, while book value per share is €175.10. Cash per share is €7.38 and free cash flow yield is 13.22%. Price-to-book at 0.37 suggests the market prices a discount to reported equity.

Technical and market signals for EXO.AS stock

Technicals point to pressure: RSI 27.32 (oversold) and MACD histogram negative. The stock sits below its 50-day average €71.08 and 200-day average €78.13. Low momentum and a rising relative volume ratio highlight outsized selling this week.

Meyka AI rates EXO.AS with a score out of 100 and forecast

Meyka AI rates EXO.AS with a score of 62.32 out of 100 — Grade B, suggestion HOLD. This grade factors S&P 500 comparison, sector and industry performance, financial growth, key metrics and analyst signals. Meyka AI’s forecast model projects a yearly target €55.80, implying -13.96% versus the current €64.85; forecasts are model-based projections and not guarantees.

Risks and catalysts ahead of the report

Catalysts: NAV revision, announced investments, and dividends from portfolio firms. Risks: earnings volatility, negative EPS trend, and interest coverage weakness. Sector context: consumer cyclical peers trade at higher PB and PE multiples, leaving EXO.AS sensitive to NAV updates.

Final Thoughts

Exor N.V. (EXO.AS) enters earnings season with a mixed profile. The stock trades at €64.85 on EURONEXT, below both its 50-day and 200-day averages. Balance-sheet metrics are strong, with book value per share €175.10 and cash per share €7.38, yet reported EPS is -2.99 and the PE is negative. Meyka AI’s model projects a yearly price of €55.80, implying -13.96% from today; that projection frames a conservative base case. For traders, immediate reaction will hinge on NAV clarity and capital allocation comments. For longer-term holders, Exor’s portfolio orientation and potential opportunistic investments remain the primary upside. We include an internal summary at the Meyka stock page for updates and real-time alerts. Remember, forecasts are model-based projections and not guarantees

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.